Brainstorm Cell Therapeutics | BCLI - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Biogen USD 18.65B 394.9M 2026-03
Brainstorm Cell Therapeutics USD -11.01M 1.02M 2026-03
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -826.57M 166.94M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Mesoblast USD 574.68M 22.76M 2025-12